Myelofibrose: Wirksamkeit der JAK1/2-Inhibition von molekularem Risiko unabhängig
Crossref DOI link: https://doi.org/10.1007/s15015-014-1311-y
Published Online: 2014-09-13
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Springer, Günter
Text and Data Mining valid from 2014-09-01
